Axcan's triple therapy gets US FDA approvable letter for of H. pylori (PharmaBiz)
Axcan Pharma Inc., a leading multinational specialty pharmaceutical company focused on gastroenterology, announced that the US Food and Drug Administration (FDA) has issued an approval letter for the company's New Drug Application for Pyleratm (formerly Helizide).

Spinach processor says Feds focused on outsiders' fields (Sacramento Business Journal)
Natural Selection Foods LLC said late Thursday that the search done at its facilities by the Food and Drug Administration and the Federal Bureau of Investigation earlier this week were focused on the fields where spinach was grown by third-party growers.

Common Compliance Approaches Leave Companies at Risk, Says Report by Aberdeen Group (SYS-CON Media)
Many manufacturers are still at risk of non-compliance despite investing considerable time, money, and staff in complying with various product content regulations worldwide, according to a new Aberdeen report.